Close
Brittany Altermatt, ANP Adult Nurse Practitioner, Gastrointestinal Oncology
Oral pill improves care of patients with bone marrow cancer: Study
Momelotinib, an oral pill taken once a day, significantly improved outcomes of patients treated for myelofibrosis (MF), a rare but fatal bone marrow cancer, researchers reported June 7. Ruben Mesa, MD, FACP, executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, presented results of the MOMENTUM phase 3 randomized […]
Using Holistic Approaches to Optimize Outcomes for Latina Breast Cancer Survivors CTMS#: 22-0043
We will assess physical functioning, daily physical activity with wearable activity monitors, biological markers (serum and salivary cortisol), diet, program adherence, as well as psycho-social measures of physical, mental, and spiritual wellbeing. In addition, BCS will be asked to describe their best day possible and their typical day. We will conduct a qualitative analysis from their responses to identify endorsement of themes.
Cancer Moonshot Retreat
Welcome to our new Senior Director of Finance and Administration
Paymon Bagheri has joined the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, as the senior director of finance and administration. Paymon is a Fellow of the American College of Healthcare Executives (FACHE), Fellow of the American College of Medical Practice Executives (FACMPE) and a certified Lean Six Sigma health […]
The New Cancer Quest and What It Means for You
Kate Lathrop, MD, highlights how the cancer center has shifted the paradigm in care for breast cancer patients and the positive impact it has made in their lives.
Innovative Device Used for Personalized Patient Treatment
Chief Medical Officer Mark Bonnen, MD, talks about an innovative device used at Mays Cancer Center to help personalize a patient’s radiation treatment and decrease the amount of radiation exposure.
Value of Offering Clinical Trials to Patients
Hear medical oncologist, Kate Lathrop, MD, share the value of offering clinical trials to patients and the potential it has to playing a key role in survivorship.